Literature DB >> 16327427

Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens.

Daniel A Arber1, Tracy I George.   

Abstract

To evaluate the features of bone trephine biopsy involvement by non-Hodgkin lymphoma, 450 specimens were evaluated for percentage of marrow involvement, pattern of involvement, presence of germinal centers or follicular structures, and discordance with other involved sites. A subset of 197 cases was evaluated for evidence of concurrent peripheral blood involvement. Follicular grade 1 lymphoma (30.4%) was the most common type to involve the marrow, followed by diffuse large B-cell lymphoma (16.0%), mantle cell lymphoma (9.3%), low-grade B-cell lymphoma, not otherwise specified (8.7%), lymphoplasmacytic lymphoma (8.4%), follicular grade 2 lymphoma (7.1%), and mature T- and NK-cell lymphomas (6.4%). A mixed pattern of infiltration was most common, followed by paratrabecular, nodular, diffuse, and interstitial patterns. Greater than 90% of follicular lymphomas had at least a focal paratrabecular infiltration pattern, but this pattern was also seen with other lymphoma types. Interstitial disease infiltration tended to correlate with lymphoplasmacytic lymphoma but was also not specific. The presence of germinal centers or follicular structures was associated with follicular lymphoma in 88% of cases. Discordance between the bone marrow morphology and other tissue sites was observed in 24.9% of cases and was most often seen with follicular or diffuse large B-cell lymphoma. Peripheral blood involvement by lymphoma was observed in 29% of cases, found in all disease groups except for follicular grade 3 lymphoma. This study highlights the frequency of different lymphoma patterns in the marrow, limitations of primary lymphoma classification on biopsy material alone, and the relative frequency of marrow discordance and peripheral blood involvement by marrow lymphoma.

Entities:  

Mesh:

Year:  2005        PMID: 16327427     DOI: 10.1097/01.pas.0000182405.65041.8b

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  29 in total

Review 1.  Discordant bone marrow involvement in non-Hodgkin lymphoma.

Authors:  Jennifer Brudno; Tamar Tadmor; Stefania Pittaluga; Alina Nicolae; Aaron Polliack; Kieron Dunleavy
Journal:  Blood       Date:  2015-12-17       Impact factor: 22.113

2.  Bone marrow trephine biopsy involvement by lymphoma: pattern of involvement and concordance with flow cytometry, in 10 years from a single institution.

Authors:  M A Cabezas-Quintario; P Gomez; V Yuste-Del Pozo; A L Valencia-Mesa; G Sosa; P Ricard; A I Hijas-Gómez; F Pinedo; M Arguelles
Journal:  Clin Transl Oncol       Date:  2015-08-27       Impact factor: 3.405

3.  Extreme hypercalcemia in a kidney transplant recipient.

Authors:  Erol Demir; Cagla Karaoglan; Gulcin Yegen; Betul Sair; Halil Yazici; Aydin Turkmen; Mehmet Sukru Sever
Journal:  CEN Case Rep       Date:  2018-04-28

4.  Nodular pattern of bone marrow infiltration: frequent finding in immunosuppression-related EBV-associated large B-cell lymphomas.

Authors:  Deborah W Sevilla; Erin M Weeden; Suzy Alexander; Vundavalli V Murty; Bachir Alobeid; Govind Bhagat
Journal:  Virchows Arch       Date:  2009-10-06       Impact factor: 4.064

5.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

6.  A Case of Primary Bone Marrow B-Cell Non Hodgkin's Lymphoma with Severe Thrombocytopenia: Case Report and A Review of the Literature.

Authors:  Yuki Kagoya; Naohi Sahara; Takashi Matsunaga; Toshimasa Uekusa; Seiji Irie; Kazuhito Hatanaka
Journal:  Indian J Hematol Blood Transfus       Date:  2010-10-06       Impact factor: 0.900

7.  Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas.

Authors:  Roopesh Kansara; Joseph M Connors; Kerry J Savage; Alina S Gerrie; David W Scott; Graham W Slack; Randy D Gascoyne; Laurie H Sehn; Diego Villa
Journal:  Haematologica       Date:  2016-06-16       Impact factor: 9.941

8.  Differentiation of single lymphoma primary cells and normal B-cells based on their adhesion to mesenchymal stromal cells in optical tweezers.

Authors:  Kamila Duś-Szachniewicz; Sławomir Drobczyński; Marta Woźniak; Krzysztof Zduniak; Katarzyna Ostasiewicz; Piotr Ziółkowski; Aleksandra K Korzeniewska; Anil K Agrawal; Paweł Kołodziej; Kinga Walaszek; Zbigniew Bystydzieński; Grzegorz Rymkiewicz
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

9.  Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement.

Authors:  Byung Woog Kang; Joon Ho Moon; Yee Soo Chae; Soo Jung Lee; Jong Gwang Kim; Yeo-Kyeoung Kim; Je-Jung Lee; Deok-Hwan Yang; Hyeoung-Joon Kim; Jin Young Kim; Young Rok Do; Keon Uk Park; Hong Suk Song; Ki Young Kwon; Min Kyung Kim; Kyung Hee Lee; Myung Soo Hyun; Hun Mo Ryoo; Sung Hwa Bae; Hwak Kim; Sang Kyun Sohn
Journal:  Cancer Res Treat       Date:  2013-06-30       Impact factor: 4.679

10.  Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China.

Authors:  Yun-Fei Shi; Xiang-Hong Li; Yu-Qin Song; Wei-Wei Song; Yu-Mei Lai
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.